Anyra (aflibercept biosimilar) / Zydus Lifesciences - LARVOL DELTA

Zydus Life launches ANYRA for advanced eye care, shares react (CNBC-TV18) - "Anyra is indicated for the treatment of neovascular (wet) Age-related Macular Degeneration (AMD), visual impairment due to macular edema secondary to Retinal Vein Occlusion (Branch RVO or Central RVO), along with other ailments."

Biosimilar launch • Retinal Vein Occlusion • Wet Age-related Macular Degeneration